what glp is tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Semaglutide & Tirzepatide Weight Loss

This segment aired on March 3, 2026.

Alternatives may include: Adjusting hormone therapy for better balance Other medications like tirzepatide or emerging GLP-1s Lifestyle-based programs tailored to menopause needs Conclusion: Semaglutide and Menopause Menopause doesnt have to mean weight gain and frustration

Current clinical studies use a weekly schedule, with dose increases over time to support tolerability

Patients included in the trial had diabetes and fulfilled the following criteria for kidney disease at the time of randomization: a urinary albumin-to-creatinine ratio (UACR) of 30300 (mg/g), estimated glomerular filtration rate (eGFR) of 2560 (ml/min/1.73m 2 ), or a UACR of 3005000 and eGFR of 2575 (ml/min/1.73m 2 ) along with diabetic retinopathy (see 17 for further details)

Some people experience plateau effects where weight loss stalls temporarily

"You don't throw up physically, but you've got that feeling and I was about two, three weeks where I felt nauseous the whole time